3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Neoplasm Metastasis
2
Colorectal Neoplasms
2
Uveal Melanoma
1
Urologic Neoplasms
1
Thyroid Neoplasms
1
Soft Tissue Neoplasms
1
Sarcoma
1
Recurrence
1
Pharyngeal Neoplasms
1
Pancreatic Neoplasms
1
Neurofibromatosis 2
1
Neoplasms, Mesothelial
1
Neoplasms
1
Myelodysplastic Syndromes
1
Mouth Neoplasms
1
Lymphangioleiomyomatosis
1
Leukemia, Myeloid, Acute
1
Erdheim-Chester Disease
1
Endocrine Gland Neoplasms
1
Disease Progression
1
Colonic Neoplasms
1
Castleman Disease
1
Carcinoma, Transitional Cell
1
Cancer That is Associated With a Chronic Viral Infection
1
Breast Neoplasms
1
Interventions
fludarabine
52
Cyclophosphamide
50
venetoclax
47
Azacitidine
44
fludarabine phosphate
41
Whole-Body Irradiation
33
Specimen Handling
31
Mycophenolic Acid
30
Tacrolimus
28
Melphalan
28
Busulfan
27
Cytarabine
25
Stem Cell Transplantation
23
Decitabine
23
Biopsy
22
Granulocyte Colony-Stimulating Factor
19
Sirolimus
16
Peripheral Blood Stem Cell Transplantation
16
Filgrastim
16
Thiotepa
15
decitabine and cedazuridine drug combination
14
Injections
13
Cyclosporine
13
ruxolitinib
9
Methotrexate
9
Mesna
9
Hematopoietic Stem Cell Transplantation
9
X-Rays
8
Idarubicin
8
Daunorubicin
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
Valproic Acid
×
1 year
×
Clear all
NCT06199557
2025-06-29
HUVAMER
Haukeland University Hospital
Phase 1/2
Recruiting
48 enrolled